Your account is not claimed yet. You can sign up with ORCID to claim your account.

Syed Nazreen

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Pharmaceuticals (Basel, Switzerland)

Archiv der Pharmazie

Turkish journal of chemistry

Nanomaterials (Basel, Switzerland)

Teva Active Pharmaceuticals Ingredients India Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Teva Active Pharmaceuticals Ingredients India Ltd Jul 15o 2012 - Jul 15o 2015

India

Research Scientiest :: CRD

Publications

Mohammad Mahboob Alam, Nawaf I Alsenani, Antar A Abdelhamid, Abrar Ahmad, Othman A Baothman, Salman A Hosawi, Hisham Altayeb, Mohammad Shahid Nadeem, Varish Ahmad, Syed Nazreen, Ahmed A Elhenawy
New paracetamol hybrids as anticancer and COX-2 inhibitors: Synthesis, biological evaluation and docking studies. Archiv der Pharmazie (2023)
Maha D Alghamdi, Syed Nazreen, Nada M Ali, Touseef Amna
ZnO Nanocomposites of Juniperus procera and Dodonaea viscosa Extracts as Antiproliferative and Antimicrobial Agents. Nanomaterials (Basel, Switzerland) 12 (4) (2022)
Shahad Ayed Alahmady, Syed Nazreen, Ali Q Alorabi, Ahmed A Elhenawy
Selective optical sensing of iron(III) ions in an aqueous medium by benzochromone-based Schiff base and its application on test strips. Environmental technology (2022)
Syed Nazreen, Abdulraheem S A Almalki, Serag Eldin I Elbehairi, Ali A Shati, Mohammad Y Alfaifi, Ahmed A Elhenawy, Nawaf I Alsenani, Anas Alfarsi, Abdulrahman Alhadhrami, Esam A Alqurashi, Mohammad Mahboob Alam
Cell Cycle Arrest and Apoptosis-Inducing Ability of Benzimidazole Derivatives: Design, Synthesis, Docking, and Biological Evaluation. Molecules (Basel, Switzerland) 27 (20) (2022)
Mohammad Mahboob Alam, Syed Nazreen, Abdulraheem S A Almalki, Ahmed A Elhenawy, Nawaf I Alsenani, Serag Eldin I Elbehairi, Azizah M Malebari, Mohammad Y Alfaifi, Meshari A Alsharif, Sulaiman Y M Alfaifi
Naproxen Based 1,3,4-Oxadiazole Derivatives as EGFR Inhibitors: Design, Synthesis, Anticancer, and Computational Studies. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Syed Nazreen
Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR-γ agonists and thymidylate synthase inhibitors. Archiv der Pharmazie 354 (9) (2021)
Abdulraheem S A Almalki, Syed Nazreen, Azizah M Malebari, Nada M Ali, Ahmed A Elhenawy, Abdullah A A Alghamdi, Abrar Ahmad, Sulaiman Y M Alfaifi, Meshari A Alsharif, Mohammad Mahboob Alam
Synthesis and Biological Evaluation of 1,2,3-Triazole Tethered Thymol-1,3,4-Oxadiazole Derivatives as Anticancer and Antimicrobial Agents. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Afnan Ahmed Alghamdi, Mohammad Mahboob Alam, Syed Nazreen
In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives. Turkish journal of chemistry 44 (4) (2020)
Mohammad Mahboob Alam, Abdulraheem S A Almalki, Thikryat Neamatallah, Nada M Ali, Azizah M Malebari, Syed Nazreen
Synthesis of New 1, 3, 4-Oxadiazole-Incorporated 1, 2, 3-Triazole Moieties as Potential Anticancer Agents Targeting Thymidylate Synthase and Their Docking Studies. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)

Syed Nazreen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Syed Nazreen